Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Trajenta“
Suchtreffer
Begriffe & Kennungen
Linagliptin
Eintrag öffnenTrajenta
Eintrag öffnenTrajenta · 4.1 Therapeutic indications · 1
Eintrag öffnenTrajenta · 4.3 Contraindications · 1
Eintrag öffnenTrajenta · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenTrajenta · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenTrajenta · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenTrajenta · 4.5 · 3 and Cmax, respectively, and about 30% decreased DPP-4 inhibition at trough. Thus, full efficacy of linaglipt
Eintrag öffnenTrajenta · 4.5 · Digoxin: co-administration of multiple daily doses of 5 mg linagliptin with multiple doses of 0.25 mg digoxin
Eintrag öffnenTrajenta · 4.5 · Effects of linagliptin on other medicinal products In clinical studies, as described below, linagliptin had no
Eintrag öffnenTrajenta · 4.5 · In vitro assessment of interactions Linagliptin is a weak competitive and a weak to moderate mechanism-based i
Eintrag öffnenTrajenta · 4.5 · In vivo assessment of interactions Effects of other medicinal products on linagliptin Clinical data described
Eintrag öffnenTrajenta · 4.5 · Metformin: co-administration of multiple daily doses of 10 mg linagliptin with 850 mg metformin, an OCT substr
Eintrag öffnenTrajenta · 4.5 · Metformin: co-administration of multiple three times daily doses of 850 mg metformin with 10 mg linagliptin on
Eintrag öffnenTrajenta · 4.5 · Oral contraceptives: co-administration with 5 mg linagliptin did not alter the steady-state pharmacokinetics o
Eintrag öffnenTrajenta · 4.5 · Rifampicin: multiple co-administration of 5 mg linagliptin with rifampicin, a potent inductor of P-glycoprotei
Eintrag öffnenTrajenta · 4.5 · Ritonavir: co-administration of a single 5 mg oral dose of linagliptin and multiple 200 mg oral doses of riton
Eintrag öffnenTrajenta · 4.5 · Simvastatin: multiple daily doses of linagliptin had a minimal effect on the steady-state pharmacokinetics of
Eintrag öffnenTrajenta · 4.5 · Sulphonylureas: co-administration of multiple oral doses of 5 mg linagliptin and a single oral dose of 1.75 mg
Eintrag öffnenTrajenta · 4.5 · Sulphonylureas: the steady-state pharmacokinetics of 5 mg linagliptin was not changed by concomitant administr
Eintrag öffnen